-
Trump secures agreements with Merck, Amgen, Novartis and others to cut drug prices under Medicaid
20 Dec 2025 02:21 GMT
… Myers Squibb, Gilead Sciences, Novartis, Amgen, Boehringer Ingelheim, Sanofi and GSK … -pay markets, including Medicare.
Merck, Amgen outline specific cuts
Merck said … through direct-to-consumer channels.
Amgen said it will expand its …
-
Takeda's Once-Daily Psoriasis Pill Hits Phase 3 Goals, Beats Amgen's Drug
18 Dec 2025 20:02 GMT
… 0 against placebo and Amgen Inc.’s (NASDAQ:AMGN) Otezla (apremilast), showing …
-
The Best Dividend ETF to Buy: SCHD Pays a High Yield While VIG Focuses on Dividend Growth
22 Dec 2025 01:16 GMT
… & Co (MRK +0.40%), Amgen (AMGN +0.91%), and Cisco Systems …
-
The Week That Was, The Week Ahead: Macro & Markets, Dec. 20
21 Dec 2025 16:20 GMT
…
Nine major pharmaceutical companies, including Amgen (AMGN), Merck (MRK), GSK (GSK), and …
-
Dividend ETF Matchup: SCHD Offers Higher Yield While VIG Leads in Growth
21 Dec 2025 02:35 GMT
… Systems (CSCO +1.91%), and Amgen (AMGN +0.91%). With more than … growth -- companies like Merck, Amgen, and Verizon, among others.
By …
-
Markets News, Dec. 19, 2025: Major Stock Indexes Close Sharply Higher for 2nd Straight Day as Tech Rally Continues; S&P 500, Nasdaq Post Weekly Gains
19 Dec 2025 14:07 GMT
… rising in response.
Shares of Amgen (AMGN), Bristol Myers Squibb (BMY), Gilead …
-
Global biotech leaders Amgen and Gilead announcing expansions in California, the #1 state for life sciences
15 Sep 2025 14:56 GMT
… today highlighted major expansions from Amgen and Gilead Sciences that will …
Earlier this month, biotechnology leader Amgen announced a $600 million investment …
-
Nine Big Pharma to cut US drug prices in Most-favoured Nations deals
22 Dec 2025 08:26 GMT
… 90 % for drugs from Amgen, BMS, Gilead, GSK, Merck … apply.
From 1 January 2026, Amgen will expand its direct-to …
-
SCHD Offers a Higher Yield While FDVV Grows Faster
22 Dec 2025 03:08 GMT
… Systems (NASDAQ:CSCO), and Amgen (NASDAQ:AMGN). The fund targets companies with … has positions in and recommends Amgen, Apple, Cisco Systems, Merck, Microsoft …
-
Celltrion launches biosimilar Stoboclo-Osenvelt in Europe
22 Dec 2025 01:46 GMT
… referencing U.S. biotech firm Amgen's osteoporosis treatment Prolia …